Rituximab maintenance in relapsed or refractory follicular non-Hodgkin's lymphoma: the evidence of its therapeutic value.

Core Evid · 2007 · PMC3012428 · PMID 21221180

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP =0.0000003actually significant

There was a highly significant difference in 4-year PFS between the maintenance and observation group (56% vs 33%, P =0.0000003), and the median PFS was increased by almost 4 years in the maintenance group (61 vs 15 months).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.